Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FIGR is a Canadian licensed producer of cannabis products, serving both the medical and adult-use recreational markets. The company operates major cultivation and processing facilities in Prince Edward Island and Ontario, utilizing a combination of traditional agricultural expertise and modern scientific standards. FIGR is notable for its proprietary traceability technology, which allows consumers to access detailed lab results and origin data for every product via a unique serial number. Their product portfolio includes premium dried flower, pre-rolls, oils, and vaporization products. Following a corporate restructuring in 2021, FIGR transitioned from being a subsidiary of Pyxus International to operating as a private entity focused on the Canadian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FIGR Cannabis.